FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

A patient who was previously classified as legally blind has regained over 50% of their vision in just a few months, thanks ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that the U.S. Food & Drug Administration (FDA) cleared its amblyopia ...

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21 ...

Amblyopia affects over 100 million people worldwide, most of them children. If left untreated, it can lead to permanent vision impairment. Traditional treatments, such as eye patching, are slow ...